Searched for
SYMBIOTEC
SAEL Industries, Vishvaraj Environment, Symbiotec Pharmalab and 3 others get Sebi nod to launch IPOSecurities and Exchange Board of India approved IPOs of six companies, including Vishvaraj Environment and SAEL Industries. Firms span sect...- Symbiotec Pharmalab plans IPO to boost specialty pharma marketSymbiotec Pharmalab, a leading API manufacturer, is planning an IPO. The company targets a valuation of about $1 billion. The IPO aims to r...
- PLI scheme: Government approves 19 applications for domestic manufacturing of APIs, key drug intermediatesFive applications with a committed investment of Rs 3,761 crore have already been approved under Target Segment I, the official statement s...
- MOPE and InvAscent buy 70% in Symbiotec for $100 mPE fund Actis sells the stake in API maker, valuing company at $140 m.
- Domestic pharmaceutical players eye Bharat Serums acquisitionThe two funds together hold a 23% stake and the remainder is with the Daftary family.
- After Gland, Chinese pharma giant Fosun eyes API maker SymbiotecSymbiotec has been an acquisition target for other drug makers and PE players after the Indore-based company was put up for sale.
- Foreign Investment Promotion Board to consider 31 FDI proposals on FridayProposals of Tevapharm India Pvt, GMU Infosoft Pvt, U Infosoft Pvt Ltd, and Monsoon Capital LLC, US are also among these nine investment pl...
- Government to consider 31 FDI proposals on December 16The government will consider 31 foreign investment proposals, including that of Ratnakar Bank, Novartis Healthcare and HDFC Bank, on Decemb...
- India Inc strikes 360 private equity deals worth $8.9 billion in January-October'There seems to be a pick-up in deal due diligence activity (especially, inbound deals) but deals are taking longer time to close,' Lahiri ...
- FIPB clears Mylan's acquisition of Strides Arcolab subsidiary Agila SpecialitiesThe board also cleared 15 foreign direct investment (FDI) proposal worth Rs 2,000 crore, the finance minister said in a statement on Friday.
- Govt clears 15 FDI proposals worth Rs 2,000.5 croreThe Finance Ministry today said it has approved 15 foreign investment proposals totalling Rs 2,000.5 crore and recommended two FDI applicat...
- FIPB clears US pharma major Mylan's Rs 5,168 crore FDI proposalUS-based Mylan Inc's Rs 5,168 crore proposal to acquire Agila Specialties Pvt Ltd -- a subsidiary of pharma firm Strides Arcolab -- was cle...
- Mylan Inc's over 5,000 crore FDI in pharma sector may get government nodMylan Inc's over Rs 5,000 crore foreign direct investment proposal and a host of others in the pharmaceutical sector could soon see green l...
- Actis to buy 25% in steroids maker Symbiotec Pharmalab for Rs 300 crorePrivate equity fund Actis is looking to purchase more than 25% stake in cortico steroids maker Symbiotec Pharmalab for around $50 million.
- Franklin Templeton PE invests Rs 45 cr in drug-maker Symbiotec PharmalabSymbiotec is engaged in research, development, manufacturing and marketing of research-based active pharmaceutical ingredients for corticos...
- Lupin picks up majority stake in SymbiotecAs part of its plan to expand in the steroids segment, pharmaceutical firm Lupin on Thursday said it has acquired a majority stake in Symbi...
- Lupin joins hands with SymbiotecLupin on Thursday said it has made an equity investment in Symbiotec Pharmalab, a company focused on steroids, for a majority stake, in a b...
Load More
